[PRESS RELEASE] – SAN DIEGO, April 7, 2025 – Robbins LLP reminds stockholders that a class action was filed on behalf of all persons and entities that purchased or otherwise acquired Canopy Growth Corp. securities between May 30, 2024, and Feb. 6, 2025. Canopy, together with its subsidiaries, produces, distributes, and sells cannabis and hemp-based products for recreational and medical purposes.
For more information, submit a form, email attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003.
The Allegations: Robbins LLP is investigating allegations that Canopy Growth Corp. misled investors regarding its cost-reduction measures.
According to the complaint, during the class period, defendants failed to disclose that: (i) Canopy had incurred significant costs producing Claybourne pre-rolled joints in connection with the Claybourne product launch in Canada; (ii) the foregoing costs, in addition to certain indirect costs that Canopy incurred in connection with its Storz & Bickel vaporizer devices, were likely to have a significant negative impact on the company’s gross margins and overall financial results; and (iii) accordingly, defendants had overstated the efficacy of Canopy’s cost reduction measures and the health of its gross margins while downplaying issues with the same.
On Feb. 7, 2025, Canopy announced disappointing financial results "primarily due to the incremental costs related to the Claybourne infused pre-roll launch in Canada, and an increase in indirect costs of Storz & Bickel vaporizer devices[.]" On this news, Canopy's share price fell 27.24%, to close at $2.02 on Feb. 7, 2025.
What Now: You may be eligible to participate in the class action against Canopy Growth Corp. Shareholders who want to serve as lead plaintiff for the class should contract Robbins LLP before June 3, 2025. The lead plaintiff is a representative party who acts on behalf of other class members in directing the litigation. You do not have to participate in the case to be eligible for a recovery. If you choose to take no action, you can remain an absent class member. For more information, click here.
All representation is on a contingency fee basis. Shareholders pay no fees or expenses.
